Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Endocrine Society’s New Testosterone Guidelines Call For More Caution, Additional Hypogonadism Testing March 19, 2018 Irvin Jackson Add Your Comments Amid continuing concerns about the health risks from testosterone replacement drugs, such as Androgel and Testim, new prescription guidelines call for doctors to ensure that men who have a confirmed diagnosis of hypogonadism, and to avoid prescribing the drugs to men with prostate cancer, breast cancer, pre-existing heart problems or who plan to have children in the near future. The Endocrine Society published its clinical practice guidelines for the evaluation and treatment of male hypogonadism late last week in the Journal of the American Medical Association (JAMA), which are designed to instruct doctors on best practices in testing men for chronically low testosterone and whether they should be treated using testosterone drugs. In recent years, television advertisements and other drug marketing has encouraged men to speak with their doctor about the use of low testosterone treatments if they experience symptoms like decreases in energy, strength, sex drive or other problems that are also linked to natural drops in testosterone levels as all men age. However, as a number of studies have highlighted the risk of heart attacks, strokes, blood clots and death that maybe caused by side effects of testosterone therapy, health experts have suggested that the medications have been widely over-prescribed to many men who have no real medical need for the treatments. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Testosterone replacement therapy, which includes blockbuster drugs like Androgel, Testim, Axiron and others, were initially expected to be a niche treatment for men suffering from testosterone deficiency caused by a medical condition, known as hypogonadism. However, as men receive prescription of the drugs for life-style reasons, the industry grew to generate more than $2 billion in sales annually in recent years. “The effects of testosterone on energy, physical performance, mood, and cardiometabolic factors continue to be explored, but in general, the treatment of hypogonadal younger men often improves symptoms related to testosterone deficiency. In contrast, testosterone treatment for middle-aged and older men with functional decline, even for those with clearly low serum testosterone levels, offers modest and inconsistent benefit,” the guidelines note. “Despite such uncertainties, ‘low T’ clinics and intensive direct-to-consumer advertising have contributed to a substantial recent increase in testosterone prescribing.” The new guidelines lay out when hypogonadism can be established; calling for two or more measurements to be taken. The guidelines say hypogonadism should be tested for in men who may have abnormal sex hormone levels, such as those suffering from obesity, diabetes, nephrotic syndrome, hypothyroidism, acromegaly, and in those taking steroids or progestins. It also calls for testing of older patients, those suffering from HIV, cirrhosis, hepatits, hyperthyroidism and in men taking estrogen or anticonvulsant medications. However, the guidelines call for much stringent use of the drugs in practice, indicating that they should only recommended for men who have diagnosed cases of hypogonadism. The Endocrine Society does not recommend testosterone use in men who plan on having children in the near future, or who have breast or prostate cancer, who have suffered a heart attack or stroke within the last six months, or men with prostate problems, untreated obstructive sleep apnea, severe lower urinary tract infections, uncontrolled heart failure or thrombophilia. The guidelines also call for doctors to only offer men over the age of 65 testosterone after they have been diagnosed for hypogonadism, and after they have had an individualized discussion about the risks and benefits. The group also calls for medical monitoring several times during the first year and on an annual basis after that. Testosterone Litigation The guidelines comes as thousands of men are now pursuing Androgel lawsuits, Testim lawsuits and other testosterone prescription lawsuits, indicating that the drug makers failed to adequately warn that they may face an increased risk of suffering a heart attack, stroke, blood clot or death while using the medications. According to allegations raised in the testosterone prescription litigation, pharmaceutical companies marketing the drugs withheld important safety warnings from consumers and the medical community, while promoting the widespread use of the medications among men without a true need for testosterone treatments. Given the similar allegations raised in the lawsuits, more than 6,500 cases filed throughout the federal court system have been consolidated for pretrial proceedings as part of a multidistrict litigation (MDL), which is centralized before U.S. District Judge Matthew Kennelly in the Northern District of Illinois. While two global testosterone settlements involving Axiron and Testim claims are expected to resolve about one-third of the pending litigation, no agreements have been reported involving Androgel cases brought against AbbVie for injuries associated with their market-leading testosterone gel product. AbbVie has already been hit with several massive jury awards in early bellwether trials, including $150 million in punitive damages in July 2017 and a verdict of $140 million in a second case in October 2017. However, the award in the first case was overturned during post-trial motions, and retrial is set for this month. Tags: AndroGel, Axiron, Breast Cancer, Heart Attack, Heart Failure, Prostate Cancer, Stroke, Testim, Testosterone Image Credit: | More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: today) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025) 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: yesterday) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025) MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 4 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (Posted: today) Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)
6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: yesterday) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 4 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)